Joel Jung

Joel Jung

Director of Finance/CFO at RENALYTIX PLC

Net worth: 5 115 $ as of 31/05/2026

68 year
Health Technology
Health Services
Consumer Services

Profile

Joel R.
Jung
's current job is Chief Financial Officer at Renalytix Plc.
Former jobs include Treasurer & Vice President at Chiron Corp.
from 2003 to 2006, Vice President-Finance at Applera Corp.
from 2006 to 2008, Chief Financial Officer at AgraQuest, Inc. from 2010 to 2012, Chief Financial Officer & Treasurer at Celera Corp.
in 2009, Chief Financial Officer at Myriad Women's Health, Inc. from 2016 to 2018, Chief Financial Officer & Vice President-Finance at Bionano Genomics, Inc. from 2014 to 2016, Vice President-Finance at Bayer CropScience LP from 2012 to 2013, Vice President- Finance at Applied Biosystems, Inc. from 2006 to 2008, and Chief Financial Officer at uBiome, Inc. in 2019.
Mr. Jung's education includes an undergraduate degree from Purdue University and an MBA from Haas School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/02/2026 210,855 ( 0.05% ) 5 115 $ 31/05/2026

Joel Jung active positions

CompaniesPositionStart
RENALYTIX PLC Director of Finance/CFO 28/05/2024

Former positions of Joel Jung

CompaniesPositionEnd
MINERVA SURGICAL, INC. Director of Finance/CFO 01/02/2024
Director of Finance/CFO 01/06/2019
Director of Finance/CFO 01/09/2018
BIONANO GENOMICS, INC. Director of Finance/CFO 01/06/2016
Director of Finance/CFO 01/07/2013
See the detail of Joel Jung's experience

Training of Joel Jung

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Process Industries

Health Services

Health Technology

Health Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Technology Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!